A synthetic peptide for use as a blocking control in assays to test for specificity of LRRC50 antibody, catalog no. 70R-3357
Background:
LRRC50 contains 6 LRR (leucine-rich) repeats. It is proposed that LRRC50 to be a novel candidate gene for human cystic kidney disease, involved in regulation of microtubule-based cilia and actin-based brush border microvilli.
| Fitzgerald Industries International, Inc. | |
|---|---|
| Product Category | Biological Materials |
| Product Number | 33R-5219 |
| Product Name | LRRC50 Blocking Peptide |